Suppr超能文献

过敏性疾病与临床耐受性中的表位特异性抗体

Epitope-Specific Antibodies in Allergic Disease and Clinical Tolerance.

作者信息

Marini-Rapoport Orlee, Bhowmik Moumita, Keswani Tarun, Patil Sarita U

机构信息

Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Food Allergy Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

出版信息

Immunol Rev. 2025 Jul;332(1):e70042. doi: 10.1111/imr.70042.

Abstract

B-cell epitope specificity on food allergens is highly relevant to understanding both the pathogenesis of IgE and IgG-mediated clinical tolerance after immunotherapy. The molecular binding interactions between the paratopes of antibodies and the epitopes of food allergens drive IgE-crosslinking, the subsequent activation of allergen effector cells, and the symptoms of systemic and life-threatening anaphylaxis. Various characteristics of allergen-specific IgE, such as high affinity and clonal diversity, can contribute to the persistence of food allergy and the severity of anaphylaxis upon allergen exposure. On the other hand, the induction of epitope-specific IgG antibodies in allergic individuals can inhibit IgE binding to food allergens. A subset of these can be neutralizing antibodies that effectively disrupt multiple allergen-IgE interactions to suppress effector responses. This review details the crucial role of epitope specificity and antibody clonality in both the pathogenesis of food allergy and in the development of clinical tolerance.

摘要

食物过敏原上的B细胞表位特异性对于理解免疫疗法后IgE介导和IgG介导的临床耐受性的发病机制都具有高度相关性。抗体互补位与食物过敏原表位之间的分子结合相互作用驱动IgE交联、随后过敏原效应细胞的激活以及全身性和危及生命的过敏反应症状。过敏原特异性IgE的各种特性,如高亲和力和克隆多样性,可导致食物过敏的持续存在以及接触过敏原时过敏反应的严重程度。另一方面,过敏个体中表位特异性IgG抗体的诱导可抑制IgE与食物过敏原的结合。其中一部分可以是中和抗体,它们能有效破坏多种过敏原-IgE相互作用以抑制效应反应。本综述详细阐述了表位特异性和抗体克隆性在食物过敏发病机制和临床耐受性发展中的关键作用。

相似文献

1
Epitope-Specific Antibodies in Allergic Disease and Clinical Tolerance.
Immunol Rev. 2025 Jul;332(1):e70042. doi: 10.1111/imr.70042.
2
Role of human antigen-specific T cells in tolerance and IgE-mediated allergic reactions to food.
Front Immunol. 2025 Jun 12;16:1595696. doi: 10.3389/fimmu.2025.1595696. eCollection 2025.
4
Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis.
Allergy. 2017 Aug;72(8):1133-1147. doi: 10.1111/all.13124. Epub 2017 May 11.
5
Moving Beyond Desensitization to Tolerance in Food Allergy.
J Allergy Clin Immunol Pract. 2025 Apr;13(4):741-744. doi: 10.1016/j.jaip.2025.02.014. Epub 2025 Feb 25.
6
Allergen-specific oral immunotherapy for peanut allergy.
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009014. doi: 10.1002/14651858.CD009014.pub2.
8
Breaking the mold: nontraditional approaches to allergen immunotherapy for environmental allergens.
Immunotherapy. 2024;16(18-19):1153-1169. doi: 10.1080/1750743X.2024.2408216. Epub 2024 Oct 9.
9
Evolution of epitope-specific IgE and IgG antibodies in children enrolled in the LEAP trial.
J Allergy Clin Immunol. 2021 Sep;148(3):835-842. doi: 10.1016/j.jaci.2021.01.030. Epub 2021 Feb 13.
10
Omeprazole inhibits IgE-mediated mast cell activation and allergic inflammation induced by ingested allergen in mice.
J Allergy Clin Immunol. 2020 Oct;146(4):884-893.e5. doi: 10.1016/j.jaci.2020.02.032. Epub 2020 Mar 16.

本文引用的文献

1
Antigenic determinants underlying IgE-mediated anaphylaxis to peanut.
J Allergy Clin Immunol. 2025 May;155(5):1595-1606.e10. doi: 10.1016/j.jaci.2024.12.1094. Epub 2025 Jan 13.
2
Structural determinants of peanut-induced anaphylaxis.
J Allergy Clin Immunol. 2025 May;155(5):1547-1556.e3. doi: 10.1016/j.jaci.2024.12.1095. Epub 2025 Jan 11.
3
Utility of epitope-specific IgE, IgG4, and IgG1 antibodies for the diagnosis of wheat allergy.
J Allergy Clin Immunol. 2024 Nov;154(5):1249-1259. doi: 10.1016/j.jaci.2024.08.003. Epub 2024 Aug 21.
4
Preclinical efficacy of peanut-specific IgG4 antibody therapeutic IGNX001.
J Allergy Clin Immunol. 2024 Nov;154(5):1241-1248.e7. doi: 10.1016/j.jaci.2024.07.014. Epub 2024 Jul 26.
6
Leaping toward Tolerance.
NEJM Evid. 2024 Jun;3(6):EVIDe2400127. doi: 10.1056/EVIDe2400127. Epub 2024 May 28.
7
Follow-up to Adolescence after Early Peanut Introduction for Allergy Prevention.
NEJM Evid. 2024 Jun;3(6):EVIDoa2300311. doi: 10.1056/EVIDoa2300311. Epub 2024 May 28.
8
Structural analysis of human IgE monoclonal antibody epitopes on dust mite allergen Der p 2.
J Allergy Clin Immunol. 2024 Aug;154(2):447-457. doi: 10.1016/j.jaci.2024.04.017. Epub 2024 Apr 30.
9
Neutralizing IgG antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy.
J Allergy Clin Immunol. 2024 Jun;153(6):1611-1620.e7. doi: 10.1016/j.jaci.2024.02.017. Epub 2024 Mar 7.
10
Defining the cross-reactivity between peanut allergens Ara h 2 and Ara h 6 using monoclonal antibodies.
Clin Exp Immunol. 2024 Mar 12;216(1):25-35. doi: 10.1093/cei/uxae005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验